2012
DOI: 10.2298/vsp1202195k
|View full text |Cite
|
Sign up to set email alerts
|

Should we prescribe “vasodilating” beta-blockers in Marfan syndrome to prevent aortic aneurysm and dissection?

Abstract: nem

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 61 publications
0
2
0
Order By: Relevance
“…Recent studies suggest benefit of vasodilator beta-blockers to control hypertension in MFS patients. 11 Patients needing additional medications to control blood pressure, especially those with chronic dissections, might be treated with an angiotensin receptor blocker in addition to ␤-blockade. 8 In patients with valve replacements, antibiotic prophylaxis and warfarin bridging should be carried out timeously, as was in this case report.…”
Section: Discussionmentioning
confidence: 99%
“…Recent studies suggest benefit of vasodilator beta-blockers to control hypertension in MFS patients. 11 Patients needing additional medications to control blood pressure, especially those with chronic dissections, might be treated with an angiotensin receptor blocker in addition to ␤-blockade. 8 In patients with valve replacements, antibiotic prophylaxis and warfarin bridging should be carried out timeously, as was in this case report.…”
Section: Discussionmentioning
confidence: 99%
“…This is also the case with the current European Society of Cardiology guidelines for the treatment of arterial hypertension from the year 2013. In these recommendations, from the beta-blocker group, vasodilating beta-blockers and highly selective beta-blockers with a better blood pressure regulation profile, better metabolic effects, and more effective reduction of the cardiovascular risk, stand out [25].…”
Section: Heart Rate and Cardiovascular Mortalitymentioning
confidence: 99%